Eli Lilly and Company is pleased to announce that we have successfully raised $500,000 in funding. As a leading medicine company dedicated to turning science into healing and improving the lives of people globally, this funding will enable us to continue our mission of advancing scientific research to address some of the world's most pressing health challenges. With a legacy of nearly 150 years rooted in innovation and a commitment to making things better, we are excited to utilize this funding to further harness the power of biotechnology, chemistry, and genetic medicine. We are grateful for the support we have received and look forward to driving impactful solutions that will make a meaningful difference in the lives of individuals around the world. For more information on our work and initiatives, please visit our website, and don't hesitate to reach out to The Lilly Answers Center for any inquiries regarding our medicines.
Biotechnology Breakthrough: Eli Lilly and Company's Seed Funding Raises $500K for Medical Innovation
Get the full Eli Lilly and Company company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
EarthOptics
EarthOptics is transforming how the world understands and manages soil. By combining next-generation sensors, advanced algorithms, and carbon analytics, we’re building the Soil Cloud—a powerful data platform that empowers farmers to sustainably optimize their operations, increase yields, and feed a growing global population. Our technology delivers high-resolution insights into soil properties at scale, making a positive impact on both environmental health and farm profitability.
$110.0M Series c
today
Otomato.xyz
Meet your Smart DeFi assistant. One setup, zero dashboards. Get hyper-targeted updates on your positions, starting with HyperEVM. ✨
$2.0M Seed
today
Waypoint Bio
Waypoint Bio is a VC-backed biotech startup building the next generation of cell therapies for solid tumors.
$20.0M Series a
today
Crimson
Crimson’s IT recruitment services simplify the recruitment process, helping hiring managers find the best contract and permanent IT talent in established and emerging disciplines. Clients and candidates alike continue to choose Crimson because of three specific reasons: A commitment to keeping promises and delivering first time, supported by a £1M investment in relationship management technology. An unparalleled network and expert market insight from over 20 years’ sector experience. A world-beating level of friendly service borne out by a world-beating Net Promotor Score. Talk to us on 01675 466 477 and discover for yourself why candidates and hiring managers choose Crimson for their IT recruitment solutions.
$2.5M Seed
today
Asteromorph
We are a team of scientists and engineers working on building scientific superintelligence. Our discovery system - an orchestration of AI models designed to drive scientific progress as an independent architect - inspires breakthrough theses and develops them to robust statements with self-conducted experiments in both silicon and physical world.
$31.4M Seed
today
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Otomato.xyz Australia | Seed | $2.0M | today |
| 2 | Crimson United Kingdom | Seed | $2.5M | today |
| 3 | Asteromorph South Korea | Seed | $31.4M | today |
| 4 |  Canals United States | Seed | $35.0M | today |
| 5 |  KUBERA United States | Seed | $6.5M | today |